Navigation Links
Genelex Corporation Defends Consumers' Right to Obtain DNA Information:
Date:1/9/2008

Company founder urges government to apply rating system to home DNA tests

to protect against 'unscrupulous and misrepresented tests'

WASHINGTON, Jan. 9 /PRNewswire/ -- Should consumers have a right to obtain information regarding their personal health through home DNA tests? According to Genelex founder, Howard Coleman, the answer is: absolutely. "I agree with scientific opinion that tens of thousands of lives can be saved each year by DNA testing that reveal potential adverse drug reactions."

Coleman believes that such specific and accurate information will be the foundation for personalized medical treatment in the 21st century. "One pill does not fit all," Coleman states.

Genelex Corporation sells home DNA tests that analyze an individual's ability to process the most commonly prescribed and over the counter medication. "More than half the population has DNA alterations that can render many medications ineffective, or worse, trigger side effects that can prove to be fatal," Coleman said. Some common medications depend upon an individual's DNA for effectiveness and safety include Tamoxifen, Coumadin, Codeine and many others.

Coleman testified Tuesday before the President's Council of Advisors on Science and Technology in Washington DC (http://www.ostp.gov/PCAST/pcast.html). While Coleman supports consumers' access to home DNA tests, he shares some of the Council's concerns that there are unscrupulous companies that don't provide accurate or useful testing. Coleman suggested that companies who sell home DNA tests should, in cooperation with government agencies, implement a rating system that describes the certainty of their predictive value. "People have a fundamental right to learn and control this information. A rating system would allow people to decide if a particular test meets their needs."

Genelex Corporation was founded in 1987, and provides a program for comprehensive personalized medication management consisting of DNA testing and software for interpreting the test results based on all of the medicines a patient is taking.

For further information about Genelex go to http://www.Genelex.com. To contact Howard Coleman, call (206) 714-6393.


'/>"/>
SOURCE Genelex Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
2. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
3. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
4. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
5. BioElectronics Corporation Announces Singapore and Malaysia Sales
6. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
7. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
8. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
9. Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference
10. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
11. Enova Medical Launches Exos Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... ... 23, 2016 , ... Supplyframe, the Industry Network for electronics ... Lab . Located in Pasadena, Calif., the Design Lab’s mission is to bring ... designed, built and brought to market. , The Design Lab is Supplyframe’s physical ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... the trading session at 4,833.32, down 0.22%; the Dow Jones ... the S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ... BIND Therapeutics Inc. (NASDAQ: BIND ). Learn more ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016 On Monday, ... call to industry to share solutions for the Biometric ... U.S. Customs and Border Protection (CBP), explains that CBP ... are departing the United States , ... and to defeat imposters. Logo - ...
(Date:6/16/2016)... 16, 2016 The global ... to reach USD 1.83 billion by 2024, according ... Inc. Technological proliferation and increasing demand in commercial ... to drive the market growth.      ... The development of advanced multimodal techniques for biometric ...
(Date:6/9/2016)... , June 9, 2016 ... Police deploy Teleste,s video security solution to ensure the safety ... France during the major tournament Teleste, ... communications systems and services, announced today that its video security ... to back up public safety across the country. ...
Breaking Biology News(10 mins):